Certified by Founder
Lodge
Maxion Therapeutics
start up
United Kingdom
- Cambridge
- 21/02/2023
- Series A
- $16,000,000
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
- Industry Biotechnology
- Website https://www.maxiontherapeutics.com/
- LinkedIn https://www.linkedin.com/company/maxion-tx/
Healthfab | $2,100,000 | (May 5, 2026)
Kibu, Inc | $10,500,000 | (May 5, 2026)
Fun | $72,000,000 | (May 5, 2026)
Featherless AI | $20,000,000 | (May 5, 2026)
LakeFusion | $7,500,000 | (May 5, 2026)
Enzo Health | $20,000,000 | (May 5, 2026)
Barocal | $10,000,000 | (May 5, 2026)
Zapdos Labs | $500,000 | (May 5, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)